<DOC>
	<DOCNO>NCT01081327</DOCNO>
	<brief_summary>Patients atrial fibrillation often anticoagulated Warfarin . Warfarin narrow therapeutic window require frequent monitoring . This study aim investigate incidence adverse event `` real world '' patient receive Warfarin lone atrial fibrillation .</brief_summary>
	<brief_title>Warfarin - How Good Are Maintaining Target Range ?</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Prescription Warfarin Atrial Fibrillation Other condition associate increase risk embolisation e.g . rheumatic valve disease , atrial mixoma . Conditions increase risk bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Safety</keyword>
</DOC>